Atlas Trials

GM-CSF With Post-Transplant Cyclophosphamide

Clinical trial NCT04237623 · RECRUITING

Trial details

NCT number
NCT04237623
Sponsor
Northside Hospital, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Transplant-Related Hematologic Malignancy
Start date
2020-05-18
Primary completion
2026-09-18
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.